Foreign-Trade Zone (FTZ) 21, Notification of Proposed Production Activity; Patheon API Inc.; (Pharmaceutical Products); Florence, South Carolina, 36753 [2024-09659]

Download as PDF Federal Register / Vol. 89, No. 87 / Friday, May 3, 2024 / Notices Tameka Owens, Assistant Administrator, Food and Nutrition Service. [FR Doc. 2024–09678 Filed 5–2–24; 8:45 am] BILLING CODE 3410–30–C CONTACT PERSON FOR MORE INFORMATION: INTERNATIONAL BROADCASTING ADVISORY BOARD Sunshine Act Meeting Notice May 7, 2024, 4 p.m.–5:30 p.m. ET May 8, 2024, 9 a.m.–9:30 a.m. ET PLACE: On May 7, 2024, the Board will meet at: Wilbur J. Cohen Building, 330 Independence Avenue SW, Washington, DC 20237 On May 8, 2024, the Board will meet at: Radio Free Asia, 2025 M Street NW, Suite 300, Washington, DC 20036 STATUS: This meeting will be closed to the public. MATTERS TO BE CONSIDERED: The International Broadcasting Advisory Board (Board) will conduct a meeting closed to the public at the dates and times listed above. Board Members (membership includes Chair Kenneth Jarin, Luis Botello, Jamie Fly, Jeffrey Gedmin, Michelle Giuda, Kathleen Matthews, Under Secretary Elizabeth Allen (Secretary of State’s Representative)), Chief Executive Officer of the U.S. Agency for Global Media (USAGM), General Counsel and Acting Board Secretary to the Board, the Secretariat to the Board, and recording secretaries will attend the closed meeting. Certain USAGM staff members who may be called on to brief or support the Board also may attend. The USAGM General Counsel and Acting Board Secretary has certified that, in his opinion, exemptions set forth in the Government in the Sunshine Act, in particular 5 U.S.C. 552b(c)(2), (6), and (9)(B), permit closure of this meeting. The Board approved the closing of this meeting. The closed meeting will focus on discussing the development of internal rules and practices to govern Board processes and functions. This includes developing processes or rules relating to IBAB, USAGM, and the USAGM networks. Publicizing these deliberations would frustrate the implementation of the very items they will be proposing. [Relates to (2), (6), and (9)(B).] In the event that the time, date, or location of this meeting changes, USAGM will post an announcement of lotter on DSK11XQN23PROD with NOTICES1 TIME AND DATE: VerDate Sep<11>2014 18:11 May 02, 2024 Jkt 262001 the change, along with the new time, date, and/or place of the meeting on its website at https://www.usagm.gov. Although a separate federal entity, USAGM prepared this notice and will continue to support the Board in accordance with 22 U.S.C. 6205(g). Persons interested in obtaining more information should contact Oanh Tran at (202) 920–2583. Authority: 5 U.S.C. 552b, 22 U.S.C. 6205(e)(3)(C). Dated: April 29, 2024. Meredith L. Meads, Executive Assistant, USAGM. [FR Doc. 2024–09853 Filed 5–1–24; 4:15 pm] BILLING CODE –P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–17–2024] Foreign-Trade Zone (FTZ) 21, Notification of Proposed Production Activity; Patheon API Inc.; (Pharmaceutical Products); Florence, South Carolina Patheon API Inc. submitted a notification of proposed production activity to the FTZ Board (the Board) for its facilities in Florence, South Carolina, within Subzone 21J. The notification conforming to the requirements of the Board’s regulations (15 CFR 400.22) was received on April 26, 2024. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/ component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board’s website—accessible via www.trade.gov/ ftz. The proposed finished products include: oseltamivir phosphate—active pharmaceutical ingredient (API); benserazide hydrochloric acid (Parkinson’s Disease finished drug); AMG 510 API; capecitabine API; MSBA–30K (methyl succinimidyl butanoic acid 30 kilodalton) API; and, PEG2–NHS (PEGinterferon with Nhyroxysuccinate) finished drug (duty rate ranges from duty-free to 6.5%). The proposed foreign-status materials and components include: resorcinol; ethyl alcohol (specifically denatured alcohol); ethyl acetate; hydrogen; hydrochloric acid; silica gel pack; PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 36753 sodium hydroxide solid and in solution; sodium hydroxide; copper II sulfate pentahydrate; palladium (catalyst); Nheptane; methylene chloride, unpreserved; methanol; benzaldehyde; pyrogallolaldehyde; glacial acetic acid; N-pentylchloroformate; 2-Bromo-5hydroxybenzoic acid; DL-serine hydrazide hydrochloride; pyridine, 99.5%; aminofuranoside; capecitabine API; sodium bicarbonate; fiber drum (cardboard); drum (high density polyethylene); drum (steel); and, drum jet ring (steel) (duty rate ranges from duty-free to 5.8%). The request indicates that certain materials/ components are subject to duties under section 301 of the Trade Act of 1974 (section 301), depending on the country of origin. The applicable section 301 decisions require subject merchandise to be admitted to FTZs in privileged foreign status (19 CFR 146.41). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is June 12, 2024. A copy of the notification will be available for public inspection in the ‘‘Online FTZ Information System’’ section of the Board’s website. For further information, contact Diane Finver at Diane.Finver@trade.gov. Dated: April 30, 2024. Elizabeth Whiteman, Executive Secretary. [FR Doc. 2024–09659 Filed 5–2–24; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE International Trade Administration [A–489–849] Certain Paper Shopping Bags From the Republic of Tu¨rkiye: Final Affirmative Determination of Sales at Less Than Fair Value; Correction Enforcement and Compliance, International Trade Administration, Department of Commerce. ACTION: Notice; correction. AGENCY: On March 18, 2024, the U.S. Department of Commerce (Commerce) published in the Federal Register its final determination in the less-than-fair value (LTFV) investigation of certain paper shopping bags (paper bags) from the Republic of Tu¨rkiye (Tu¨rkiye). In that notice, Commerce incorrectly included the company name ‘‘Umur Basim’’ in the rate table. FOR FURTHER INFORMATION CONTACT: Jeff Pedersen, AD/CVD Operations, Office SUMMARY: E:\FR\FM\03MYN1.SGM 03MYN1

Agencies

[Federal Register Volume 89, Number 87 (Friday, May 3, 2024)]
[Notices]
[Page 36753]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09659]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-17-2024]


Foreign-Trade Zone (FTZ) 21, Notification of Proposed Production 
Activity; Patheon API Inc.; (Pharmaceutical Products); Florence, South 
Carolina

    Patheon API Inc. submitted a notification of proposed production 
activity to the FTZ Board (the Board) for its facilities in Florence, 
South Carolina, within Subzone 21J. The notification conforming to the 
requirements of the Board's regulations (15 CFR 400.22) was received on 
April 26, 2024.
    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material(s)/component(s) and 
specific finished product(s) described in the submitted notification 
(summarized below) and subsequently authorized by the Board. The 
benefits that may stem from conducting production activity under FTZ 
procedures are explained in the background section of the Board's 
website--accessible via www.trade.gov/ftz.
    The proposed finished products include: oseltamivir phosphate--
active pharmaceutical ingredient (API); benserazide hydrochloric acid 
(Parkinson's Disease finished drug); AMG 510 API; capecitabine API; 
MSBA-30K (methyl succinimidyl butanoic acid 30 kilodalton) API; and, 
PEG2-NHS (PEGinterferon with N-hyroxysuccinate) finished drug (duty 
rate ranges from duty-free to 6.5%).
    The proposed foreign-status materials and components include: 
resorcinol; ethyl alcohol (specifically denatured alcohol); ethyl 
acetate; hydrogen; hydrochloric acid; silica gel pack; sodium hydroxide 
solid and in solution; sodium hydroxide; copper II sulfate 
pentahydrate; palladium (catalyst); N-heptane; methylene chloride, 
unpreserved; methanol; benzaldehyde; pyrogallolaldehyde; glacial acetic 
acid; N-pentylchloroformate; 2-Bromo-5-hydroxybenzoic acid; DL-serine 
hydrazide hydrochloride; pyridine, 99.5%; aminofuranoside; capecitabine 
API; sodium bicarbonate; fiber drum (cardboard); drum (high density 
polyethylene); drum (steel); and, drum jet ring (steel) (duty rate 
ranges from duty-free to 5.8%). The request indicates that certain 
materials/components are subject to duties under section 301 of the 
Trade Act of 1974 (section 301), depending on the country of origin. 
The applicable section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is June 12, 2024.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Diane Finver at 
[email protected].

    Dated: April 30, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-09659 Filed 5-2-24; 8:45 am]
BILLING CODE 3510-DS-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.